Spyre Therapeutics (SYRE) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Form S-3ASR Spyre Therapeutics, Inc.
June 26, 2026 4:06 PM EDTAs filed with the Securities and Exchange Commission on June 26, 2026. Registration No.... More
